2024 U.S. Hospital Hemostasis Diagnostics Market Supplier Shares Sales Segment Forecasts
This new report from .com is available by section, and can be customized to specific information needs and budget. The report presents a comprehensive analysis of the US hospital hemostasis diagnostic testing market, including:
- Major issues pertaining to the US hospital coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- Volume and sales forecasts for 40 coagulation procedures performed in US hospitals, including typical coagulation daily work loads.
- Review of current instrumentation technologies, and a feature comparison of leading analyzers.
- Reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of coagulation technologies and their potential market applications.
- Major opportunities for new coagulation instruments and consumables.
- Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for instrument and reagent suppliers.
II. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrands Factor
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their
Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Molecular Diagnostics
5. Microcomputers
6. Automation
7. Robotics
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument
and Reagent Suppliers Sales and Market Shares
IV. Major Product Development Opportunities
V. Design Criteria For Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
The report provides strategic assessments of over 20 leading coagulation
market players and start-up companies with innovative technologies and
products, including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others
List Of Tables
Major Companies Developing or Marketing Activated Clotting Time TestsMajor Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrands
Factor Tests
Executive Summary Table: U.S.A., Hospital Coagulation Diagnostics
Market By Product Category
U.S.A., Hospital Laboratories Performing Coagulation Tests
By Bed Size
U.S.A., Hospital Laboratories Average Daily Test Volume
U.S.A., Hospital Laboratories Coagulation Test Volume by Assay
U.S.A., Major Suppliers of Coagulation Reagents,
Estimated Sales and Market Shares
U.S.A., Major Suppliers of Coagulation Analyzers,
Estimated Sales and Market Shares
U.S.A., Coagulation Diagnostics Market By Product Category
U.S.A., Major Suppliers of Coagulation Diagnostic Products,
Estimated Sales and Market Shares
List Of Figures
Competitive AssessmentsAbbott
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix
Diagnostica Stago
Grifols
Helena Laboratories
HYPHEN BioMed
Instrumentation
Laboratory/Werfen
Nexus Dx
Roche
Sekisui Diagnostics
Siemens Healthineers
Sienco
Sysmex
Thermo Fisher
2024 Allscripts Healthcare Solutions First Half Operating Financial Review
2024 Allscripts Healthcare Solutions First Half Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Healthcare Industry This report is part of the
USD 750 View Report2024 Welltower First Half Operating and Financial Review
2024 Welltower First Half Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Healthcare Industry This report is part of the Competitive Analysis
USD 750 View Report2024 U.S. Infectious Disease Molecular Diagnostics Market
2024 U.S. Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review The report is available by section, market segment, individual test, and can
USD 4500 View Report2024 U.S. Coagulation Testing Market
2024 U.S. Coagulation Testing Market--Hemostasis Analyzers and Consumables--2023 Supplier Shares, 2023-2028 Segment Volume and Sales Forecasts for over 40 Coagulation Assays, Opportunities for Suppliers--Molecular, Chromogenic and Immunodiagnostic Hemostasis Tests--Growth Strategies,
USD 3500 View ReportFill The Form For Sample Request